Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)

Study ID: NCT06672419
Start Date: 2025-12-01
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

AI-Guided Exercise and Pain Neuroscience Education

Usual Care for Fibromyalgia

Sponsor

Marco Antonio Morales Osorio

Source: clinicaltrials.gov

Share:
Add to list

Inhaler Trainer Efficacy Study

Study ID: NCT06461403
Start Date: 2025-10-01
End Date: 2026-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Inhaler Trainer System

Initial Inhaler Use Assessment

Inhaler Use Instruction

Sponsor

Koronis Biomedical Technologies

Source: clinicaltrials.gov

Share:
Add to list

Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study

Study ID: NCT07151456
Start Date: 2026-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

224

Intervention / Treatment

Conventional 24-week glucocorticoid regimen

short-term course (12 week) glucocorticoid regimen

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Source: clinicaltrials.gov

Share:
Add to list

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

Study ID: NCT06954831
Start Date: 2025-10-05
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

82

Intervention / Treatment

Cone-Beam Computed Tomography

Hypofractionated External Beam Radiation Therapy

Administration questionnaire

Radiation Boost

Whole Breast Irradiation

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus

Study ID: NCT06789302
Start Date: 2025-12
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

DT2-SCT intravenous infusion

Placebo

Sponsor

Global Institute of Stem Cell Therapy and Research

Source: clinicaltrials.gov

Share:
Add to list

Smart Olfaction App to Reduce Relapse

Study ID: NCT07007195
Start Date: 2025-10-17
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

132

Intervention / Treatment

Ad Libitum Use followed by Instructed Use of the Inspire Device

Instructed Use followed by Ad Libitum Use of the Inspire Device

Smart-T Smoking Cessation App with the Inspire Device Condition

Smart-T Smoking Cessation App Without the Inspire Device Condition

Nicotine replacement therapy (NRT)

Inspire Device

Sponsor

University of Houston

Source: clinicaltrials.gov

Share:
Add to list

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Study ID: NCT07061951
Start Date: 2025-10-31
End Date: 2027-12-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Echocardiography Test

Mirdamet

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Long-term Impact of NMDAR Encephalitis, Level 3

Study ID: NCT07158229
Start Date: 2025-10-01
End Date: 2026-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Questionnaires

Sponsor

Lyon Civilian Hospices

Source: clinicaltrials.gov

Share:
Add to list

Addressing Parental Tobacco Use in Somali Immigrant Families: Adapting an Evidence-Based Intervention in Primary Care

Study ID: NCT06839729
Start Date: 2027-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

CEASE+

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Validation of the French Version of the OSA-18 Questionnaire

Study ID: NCT07136909
Start Date: 2025-11-01
End Date: 2027-04-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Completion of the OSA-18 questionnaire by parents, during hospitalization planned as part of routine care.

Sponsor

Lyon Civilian Hospices

Source: clinicaltrials.gov

Share:
Add to list